Aberdeen Group’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43.8M | Buy |
287,840
+43,083
| +18% | +$7.18M | 0.06% | 247 |
|
|
2026
Q1 | $51.4M | Buy |
244,757
+19,328
| +9% | +$4.86M | 0.08% | 206 |
|
|
2025
Q4 | $64.1M | Buy |
225,429
+70,607
| +46% | +$22.1M | 0.1% | 165 |
|
|
2025
Q3 | $47.8M | Buy |
154,822
+11,571
| +8% | +$3.63M | 0.08% | 215 |
|
|
2025
Q2 | $45M | Sell |
143,251
-25,932
| -15% | -$7.48M | 0.08% | 225 |
|
|
2025
Q1 | $43.9M | Sell |
169,183
-13,892
| -8% | -$3.76M | 0.09% | 212 |
|
|
2024
Q4 | $47.9M | Sell |
183,075
-19,046
| -9% | -$4.8M | 0.09% | 211 |
|
|
2024
Q3 | $46.7M | Sell |
202,121
-33,483
| -14% | -$6.88M | 0.09% | 225 |
|
|
2024
Q2 | $47.5M | Sell |
235,604
-54,234
| -19% | -$9.77M | 0.09% | 217 |
|
|
2024
Q1 | $49.7M | Sell |
289,838
-15,516
| -5% | -$2.89M | 0.1% | 218 |
|
|
2023
Q4 | $66.3M | Sell |
305,354
-11,574
| -4% | -$1.99M | 0.14% | 157 |
|
|
2023
Q3 | $50.5M | Sell |
316,928
-51,834
| -14% | -$11.6M | 0.13% | 161 |
|
|
2023
Q2 | $106M | Buy |
368,762
+15,774
| +4% | +$4.79M | 0.25% | 93 |
|
|
2023
Q1 | $113M | Buy |
352,988
+26,289
| +8% | +$7.79M | 0.28% | 84 |
|
|
2022
Q4 | $96.2M | Sell |
326,699
-15,459
| -5% | -$4.26M | 0.26% | 88 |
|
|
2022
Q3 | $78.5M | Buy |
342,158
+75,275
| +28% | +$18.9M | 0.23% | 94 |
|
|
2022
Q2 | $58.5M | Buy |
266,883
+4,229
| +2% | +$961K | 0.18% | 111 |
|
|
2022
Q1 | $70M | Buy |
262,654
+30,387
| +13% | +$7.46M | 0.18% | 124 |
|
|
2021
Q4 | $61.8M | Sell |
232,267
-49,057
| -17% | -$14.2M | 0.14% | 157 |
|
|
2021
Q3 | $79.2M | Sell |
281,324
-40,342
| -13% | -$11.5M | 0.18% | 123 |
|
|
2021
Q2 | $88.4M | Sell |
321,666
-37,955
| -11% | -$10.3M | 0.19% | 111 |
|
|
2021
Q1 | $93.8M | Buy |
359,621
+6,308
| +2% | +$1.69M | 0.21% | 102 |
|
|
2020
Q4 | $90.3M | Buy |
353,313
+10,249
| +3% | +$2.54M | 0.22% | 105 |
|
|
2020
Q3 | $81.3M | Buy |
343,064
+54,580
| +19% | +$11.5M | 0.22% | 106 |
|
|
2020
Q2 | $56M | Sell |
288,484
-47
| -0% | -$8.98K | 0.15% | 128 |
|
|
2020
Q1 | $47.8M | Sell |
288,531
-67,281
| -19% | -$12.3M | 0.15% | 126 |
|
|
2019
Q4 | $60.9M | Buy |
355,812
+5,742
| +2% | +$957K | 0.15% | 122 |
|
|
2019
Q3 | $57.7M | Buy |
350,070
+16,440
| +5% | +$2.31M | 0.14% | 125 |
|
|
2019
Q2 | $39.8M | Buy |
333,630
+46,378
| +16% | +$4.75M | 0.09% | 204 |
|
|
2019
Q1 | $27.3M | Buy |
287,252
+78,230
| +37% | +$6.71M | 0.06% | 295 |
|
|
2018
Q4 | $16M | Buy |
+209,022
| New | +$17.7M | 0.04% | 367 |
|
Other funds holding PODD
Aberdeen Group's PODD Position: Q2 2026 in Review
Aberdeen Group increased its Insulet (PODD) stake by 18% in Q2 2026, buying an estimated $7.18M and bringing the position to 287,840 shares worth $43.8M. The position accounts for 0.06% of the portfolio, ranked #247.
Aberdeen Group first reported a position in PODD in Q4 2018 and has held it in 31 quarters since. The position peaked at $113M in Q1 2023. 732 funds tracked by Wall St. Rank hold PODD as of Q2 2026.
- Aberdeen Group held 287,840 shares of Insulet worth $43.8M as of Q2 2026.
- Aberdeen Group bought 43,083 Insulet shares in Q2 2026, an estimated $7.18M.
- Insulet made up 0.06% of Aberdeen Group's portfolio in Q2 2026, its #247 holding.
- Aberdeen Group first reported a position in Insulet in Q4 2018 and has held it in 31 quarters since.
- Aberdeen Group's Insulet position peaked at $113M in Q1 2023.
- 732 funds tracked by Wall St. Rank held Insulet as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.